跳至主要内容
临床试验/NCT02482545
NCT02482545已完成不适用

Breakfast Meal Replacement Use on Body Composition and Health-related Quality of Life in Overweight Men and Women: a Randomized Controlled Trial

University of North Carolina, Chapel Hill2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2015年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
2
主要终点
Change in Fat Mass measured from multi-compartment (4C) model

研究概览

简要总结

Purpose: To evaluate the effects of replacing breakfast with a high protein, high fat, high fiber meal replacement in overweight individuals, on body composition.

Participants: Healthy, overweight and obese individuals (ages 18-45 yrs) with no history of disease. Procedures (methods): In a randomized control intervention, subjects will complete 5 different testing sessions (pre-screening, 2 baseline testing sessions, and 2 post testing sessions) as well as an 8 week intervention period. Pre-screening will include written informed consent, health history questionnaire, nutrition analysis, and baseline anthropometric measures. Baseline testing will be split into two sessions and include measurements of resting metabolic rate (RMR), body composition, blood and saliva hormones, mood, satiety, and health related quality of life questionnaires, and a cardiorespiratory fitness assessment.

Subjects will be randomly assigned to treatment (8 week supplementation with meal replacement to be taken at breakfast) and control groups (continue normal eating habits) with 4 electronic correspondences throughout the supplementation period. All measures will be repeated in two post-testing sessions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy, Overweight Men and Pre-Menopausal Women
  • Participant agrees to maintain usual activity lifestyle
  • Participant has a body mass index of ≥ 28 (men) and ≥25 (women) kg/m2 and/or %body fat of ≥ 25%
  • Participant has provided written and dated informed consent to participate in the study
  • Participant is willing and able to comply with the protocol
  • Participant is apparently healthy and free from disease, as determined by a health history questionnaire (diabetes, heart disease, kidney disease, cancer, thyroid disorder, etc).
  • Participant agrees to abstain from smoking, caffeine, tobacco, and alcohol before testing days
  • Participant has stated a goal of losing weight or improving body composition

排除标准

  • Having a history of medical or surgical events that may significantly affect the study outcome, including cardiovascular disease, metabolic, renal, hepatic, or musculoskeletal disorders (i.e. anything influencing exercise ability).
  • Participant is using, or has used one of the following dietary supplements within 8 weeks prior to enrollment: Meal replacement shakes, Whey Protein, Beta-alanine, Creatine, beta-hydroxy beta methylbutyrate, Carnosine or Taurine
  • Participant has lost or gained greater than ten pounds within the previous 3 months
  • Participant is in, or has participated in another clinical trial within 4 weeks prior to enrollment
  • Participant had or currently has a self-identified eating disorder
  • Participant is pregnant or plans to become pregnant during the duration of the study
  • Participant has a known allergy or sensitivity to any ingredient in the test product or placebo (determined from health history questionnaire)

结局指标

主要结局

Change in Fat Mass measured from multi-compartment (4C) model

时间窗: 0 to 8 weeks

次要结局

  • Change in satiety via questionnaire(0 to 8 weeks)
  • Change in percent body fat measured from multi-compartment (4C) model(0 to 8 weeks)
  • Change in lean mass measured from multi-compartment (4C) model(0 to 8 weeks)
  • Change in resting metabolic rate using indirect calorimetry(0 to 8 weeks)
  • Change in total leptin concentrations from blood sample analysis(0 to 8 weeks)
  • Change in LDL from blood sample analysis(0 to 8 weeks)
  • Change in insulin from blood sample analysis(0 to 8 weeks)
  • Change in respiratory exchange ratio using indirect calorimetry(0 to 8 weeks)
  • Change in triglycerides from blood sample analysis(0 to 8 weeks)
  • Change in visceral fat from ultrasonography(0 to 8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Abbie Smith-Ryan, PhD

Assistant Professor

University of North Carolina, Chapel Hill

研究点 (2)

Loading locations...

相似试验